CELC
Price
$13.40
Change
+$0.06 (+0.45%)
Updated
Jul 8 closing price
Capitalization
507.41M
29 days until earnings call
CGON
Price
$25.99
Change
-$0.26 (-0.99%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
1.98B
29 days until earnings call
Interact to see
Advertisement

CELC vs CGON

Header iconCELC vs CGON Comparison
Open Charts CELC vs CGONBanner chart's image
Celcuity
Price$13.40
Change+$0.06 (+0.45%)
Volume$150.17K
Capitalization507.41M
CG Oncology
Price$25.99
Change-$0.26 (-0.99%)
Volume$15.25K
Capitalization1.98B
CELC vs CGON Comparison Chart in %
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELC vs. CGON commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a StrongBuy and CGON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (CELC: $13.40 vs. CGON: $25.96)
Brand notoriety: CELC and CGON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 86% vs. CGON: 80%
Market capitalization -- CELC: $507.41M vs. CGON: $1.98B
CELC [@Biotechnology] is valued at $507.41M. CGON’s [@Biotechnology] market capitalization is $1.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whileCGON’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • CGON’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 4 TA indicator(s) are bullish while CGON’s TA Score has 2 bullish TA indicator(s).

  • CELC’s TA Score: 4 bullish, 4 bearish.
  • CGON’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, CELC is a better buy in the short-term than CGON.

Price Growth

CELC (@Biotechnology) experienced а +7.29% price change this week, while CGON (@Biotechnology) price change was -1.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

CELC is expected to report earnings on Nov 17, 2025.

CGON is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($1.98B) has a higher market cap than CELC($507M). CELC YTD gains are higher at: 2.368 vs. CGON (-9.484). CELC has higher annual earnings (EBITDA): -114.96M vs. CGON (-134.35M). CGON has more cash in the bank: 688M vs. CELC (206M). CGON has less debt than CELC: CGON (1.04M) vs CELC (98.7M). CGON has higher revenues than CELC: CGON (662K) vs CELC (0).
CELCCGONCELC / CGON
Capitalization507M1.98B26%
EBITDA-114.96M-134.35M86%
Gain YTD2.368-9.484-25%
P/E RatioN/AN/A-
Revenue0662K-
Total Cash206M688M30%
Total Debt98.7M1.04M9,527%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELCCGON
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 23 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AWAYX22.98N/A
N/A
AB Wealth Appreciation Strategy Advisor
RSIPX15.28N/A
N/A
Columbia Disciplined Core Inst2
NCLEX29.23N/A
N/A
Nicholas Limited Edition I
GQFIX12.18N/A
N/A
GQG Partners Global Quality Value Fd Ins
ISMVX10.74N/A
N/A
William Blair Small-Mid Cap Value I

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-1.10%
IDYA - CGON
60%
Loosely correlated
+1.37%
SYRE - CGON
58%
Loosely correlated
+2.03%
ACLX - CGON
57%
Loosely correlated
+1.54%
NUVL - CGON
55%
Loosely correlated
+1.08%
KRYS - CGON
54%
Loosely correlated
+2.57%
More